Added benefits of drospirenone for compliance.

@article{Foidart2005AddedBO,
  title={Added benefits of drospirenone for compliance.},
  author={J. M. Foidart},
  journal={Climacteric : the journal of the International Menopause Society},
  year={2005},
  volume={8 Suppl 3},
  pages={28-34}
}
  • J. M. Foidart
  • Published 2005 in
    Climacteric : the journal of the International…
Drospirenone is a novel progestogen that possesses antimineralocorticoid activity. This activity is seen clinically in its effects on physiological parameters, body weight, general well-being and fluid-related symptoms. Clinical studies with an oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (Yasmin, Schering AG, Berlin, Germany) and a new continuous combined oral hormone replacement therapy (HRT) containing 1 mg 17beta-estradiol and 2 mg drospirenone (Angeliq… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Oral contraceptives containing drospirenone for premenstrual syndrome.

The Cochrane database of systematic reviews • 2009
View 7 Excerpts
Highly Influenced

Oral contraceptives containing drospirenone for premenstrual syndrome.

The Cochrane database of systematic reviews • 2008
View 6 Excerpts
Highly Influenced

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception • 2017
View 1 Excerpt

Therapeutic management of premenstrual syndrome.

Expert opinion on pharmacotherapy • 2010
View 1 Excerpt

The effects of hormones on urinary incontinence in postmenopausal women.

Climacteric : the journal of the International Menopause Society • 2009

Similar Papers

Loading similar papers…